Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishaka Gopalan

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cell Reports|September 21, 2022
Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumorXiyuan Zhang, Hannah E Lou, Vishaka Gopalan, et al.
Cell|March 25, 2021
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasisSabina Kaczanowska, Daniel W Beury, Vishaka Gopalan, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Transitory Schwann Cell Precursor and hybrid states underpin melanoma therapy resistance and metastasisVishaka Gopalan, Chun Wai Wong, Rotem Leshem, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
IMMUNE AND MOLECULAR CORRELATES OF RESPONSE TO IMMUNOTHERAPY REVEALED BY BRAIN-METASTATIC MELANOMA MODELSAmélie Daugherty-Lopès, Eva Pérez-Guijarro, Vishaka Gopalan, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Melanoma clonal subline analysis uncovers heterogeneity-driven immunotherapy resistance mechanismsCharli Gruen, Howard H Yang, Antonella Sassano, et al.
Nature Communications|September 26, 2023
PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer modelsChun Wai Wong, Christos Evangelou, Kieran N Sefton, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cell Reports|September 21, 2022
Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumorXiyuan Zhang, Hannah E Lou, Vishaka Gopalan, et al.
Cell|March 25, 2021
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasisSabina Kaczanowska, Daniel W Beury, Vishaka Gopalan, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Transitory Schwann Cell Precursor and hybrid states underpin melanoma therapy resistance and metastasisVishaka Gopalan, Chun Wai Wong, Rotem Leshem, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
IMMUNE AND MOLECULAR CORRELATES OF RESPONSE TO IMMUNOTHERAPY REVEALED BY BRAIN-METASTATIC MELANOMA MODELSAmélie Daugherty-Lopès, Eva Pérez-Guijarro, Vishaka Gopalan, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Melanoma clonal subline analysis uncovers heterogeneity-driven immunotherapy resistance mechanismsCharli Gruen, Howard H Yang, Antonella Sassano, et al.
Nature Communications|September 26, 2023
PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer modelsChun Wai Wong, Christos Evangelou, Kieran N Sefton, et al.
Pageof 3